FDA Approves Additional Information in Labeling for Kybella (Deoxycholic Acid) Injection ...

The FDA has approved new labeling warnings for Kybella (deoxycholic acid) injection regarding serious adverse events from off-label use outside the submental fat region and risks of injection site nodules and masses even when used as approved. This update follows review of adverse event reports and underscores increased caution for healthcare providers and patients.

This Wire brief sits within Fusion42's coverage of Health.